Position in AMGN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$556,577
-$12,716 QoQ
Shares Held
1,537
-5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,107
of 3,149 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DRIVE WEALTH MANAGEMENT, LLC holds $10,951,159 across 10 Drug Manufacturers - General names. AMGN ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,080 | $3,694,244 | |
| 2 | ABBV |
AbbVie Inc.
|
6,804 | $1,712,158 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,904 | $1,401,164 | |
| 4 | JNJ |
Johnson & Johnson
|
4,782 | $1,214,484 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,082 | $811,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,429 | $559,559 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,537 | $556,577 | |
| 8 | AZN |
Astrazeneca PLC
|
2,156 | $408,820 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $556,577 | 1,537 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $569,293 | 1,618 | Shares | Other | 2026-04-14 | |
| 2025-12-31 | $459,870 | 1,405 | Shares | Other | 2026-02-04 | |
| 2025-09-30 | $281,917 | 999 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $211,920 | 759 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $306,253 | 983 | Shares | Other | 2025-05-07 | |
| 2024-12-31 | $236,139 | 906 | Shares | Sole | 2025-01-22 | |
| 2022-12-31 | $253,447 | 965 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $202,860 | 900 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $227,728 | 936 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $247,865 | 1,025 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||